Citations

Showing 10 of 108135 citations.

Management of Myocarditis-Related Cardiomyopathy in Adults
Tschöpe, Carsten , Cooper, Leslie T. , Torre‐Amione, Guillermo , Linthout, Sophie Van , Cooper, Leslie T , Tschöpe, Carsten

Mayo Clinic

Circulation Research | May 23, 2019 | Volume: 124 | Issue: 11 | Pages: 1568-1583

10.1161/circresaha.118.313578 | PMID 31120823 Get It

Myocarditis is generally a mild and self-limited consequence of systemic infection of cardiotropic viruses. However, patients can develop a temporary or permanent impairment of cardiac function including acute cardiomyopathy with hemodynamic compromise or severe arrhythmias. In this setting, specific causes of inflammation are associated with variable risks of death and transplantation. Recent translational studies suggest that treatments tailored to specific causes of myocarditis may impact clinical outcomes when added to guideline-directed medical care. This review summarizes recent advances in translational research that influence the utility of endomyocardial biopsy for the management of inflammatory cardiomyopathies. Emerging therapies for myocarditis based on these mechanistic hypotheses are entering clinical trials and may add to the benefits of established heart failure treatment.
White matter hyperintensities: relationship to amyloid and tau burden
Graff‐Radford, Jonathan , Arenaza‐Urquijo, Eider M. , Brown, Robert D. , Gunter, Jeffrey L. , Senjem, Matthew L. , Przybelski, Scott A. , Lesnick, Timothy G. , Ward, Chadwick P., Lowe, Val J. , Petersen, Ronald C. , Kremers, Walter K. , Kantarci, Kejal , Jack, Clifford R. , Vemuri, Prashanthi , Lesnick, Timothy, Ward, Chadwick, Jack, Clifford R , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal , Arenaza-Urquijo, Eider M , Kremers, Walter K , Knopman, David S. , Schwarz, Christopher G. , Rabinstein, Alejandro A. , Mielke, Michelle M.

Mayo Clinic

Brain | May 23, 2019 | Volume: 142 | Issue: 8 | Pages: 2483-2491

10.1093/brain/awz162 | PMID 31199475 Get It

Abstract Although white matter hyperintensities have traditionally been viewed as a marker of vascular disease, recent pathology studies have found an association between white matter hyperintensities and Alzheimer’s disease pathologies. The objectives of this study were to investigate the topographic patterns of white matter hyperintensities associated with Alzheimer’s disease biomarkers measured using PET. From the population-based Mayo Clinic Study of Aging, 434 participants without dementia (55% male) with FLAIR and gradient recall echo MRI, tau-PET (AV-1451) and amyloid-PET scans were identified. A subset had cerebral microbleeds detected on T2* gradient recall echo scans. White matter hyperintensities were semi-automatically segmented using FLAIR MRI in participant space and normalized to a custom template. We used statistical parametric mapping 12-based, voxel-wise, multiple-regression analyses to detect white matter hyperintense regions associated with Alzheimer’s biomarkers (global amyloid from amyloid-PET and meta-regions of interest tau uptake from tau-PET) after adjusting for age, sex and hypertension. For amyloid associations, we additionally adjusted for tau and vice versa. Topographic patterns of amyloid-associated white matter hyperintensities included periventricular white matter hyperintensities (frontal and parietal lobes). White matter hyperintense volumes in the detected topographic pattern correlated strongly with lobar cerebral microbleeds (P < 0.001, age and sex adjusted Cohen’s d = 0.703). In contrast, there were no white matter hyperintense regions significantly associated with increased tau burden using voxel-based analysis or region-specific analysis. Among non-demented elderly, amyloid load correlated with a topographic pattern of white matter hyperintensities. Further, the amyloid-associated, white matter hyperintense regions strongly correlated with lobar cerebral microbleeds suggesting that cerebral amyloid angiopathy contributes to the relationship between amyloid and white matter hyperintensities. The study did not support an association between increased tau burden and white matter hyperintense burden.
His-bundle pacing: impact of social media
Beer, Dominik , Dandamudi, Gopi, Friedman, Paul A. , Vijayaraman, Pugazhendhi , Mandrola, John M

Mayo Clinic

EP Europace | May 23, 2019 | Volume: 21 | Issue: 10 | Pages: 1445-1450

10.1093/europace/euz169 | PMID 31230085 Get It

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer
Wassermann, Johanna , Gelber, Shari , Rosenberg, Shoshana M. , Ruddy, Kathryn J. , Schapira, Lidia , Come, Steven E. , Meyer, Meghan E., Partridge, Ann H. , Partridge, Ann H , Tamimi, Rulla M. , Borges, Virginia F.

Mayo Clinic

Cancer | May 23, 2019 | Volume: 125 | Issue: 18 | Pages: 3266-3274

10.1002/cncr.32192 | PMID 31120571 Get It

Background Young age is a known factor associated with suboptimal adherence to endocrine therapy (ET) for adjuvant breast cancer (BC) treatment. This study was aimed at assessing nonadherent behaviors and associated factors among young women with early‐stage hormone receptor–positive BC. Methods As part of a multicenter, prospective cohort of women with a diagnosis of BC at or under the age of 40 years, participants were surveyed 30 months after their diagnosis about adherent behaviors. Among those who reported taking ET, adherence was measured with a 3‐item Likert‐type scale: Do you ever forget to take your ET? If you feel worse when you take your ET, do you stop taking it? Did you take your ET exactly as directed by your doctor over the last 3 months? Women reporting at least 1 nonadherent behavior were classified as nonadherers. Variables with a P value <.20 were included in a multivariable logistic model. Results Among 384 women, 194 (51%) were classified as nonadherers. Univariate factors that retained significance in the multivariable model included educational level (odds ratio [OR], 0.50 for high vs low; P = .04), level of social support according to the Medical Outcome Study Social Support Survey (OR, 0.98 per 1 point; P = .01), and confidence with the decision regarding ET measured on a 0 to 10 numerical scale (OR, 0.63 for high vs low; P = .04). Conclusions Findings from this study could help to identify young patients at higher risk for nonadherence. Interventions adapted to the level of education and aimed at reinforcing support and patients' confidence in their decision to take ET could improve adherence and associated outcomes in this population.
Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial
Inman, Brant A. , Davis, Leah , Kassouf, Wassim , Messing, Edward M. , Canter, Daniel , Marble, H. Tony, Joseph, Ajith M. , Jewell, Susan, Boorjian, Stephen A. , Inman, Brant A , Lotan, Yair , Daneshmand, Siamak , Marble, H. T.

Mayo Clinic

Journal of Urology | May 23, 2019 | Volume: 202 | Issue: 5 | Pages: 920-926

10.1097/ju.0000000000000355 | PMID 31120373 Get It

Faculty Opinions recommendation of Microglia enhance synapse activity to promote local network synchronization.
Wu, Long‐Jun , Eyo, Ukpong B

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 23, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.734225279.793560354 Get It

Management of Patients with Heart Failure: Focus on New Pharmaceutical and Device Options
Inampudi, Chakradhari , Hatzis, Georgios, Asleh, Rabea , Briasoulis, Αlexandros

Mayo Clinic

Current Medicinal Chemistry | May 23, 2019 | Volume: 27 | Issue: 27 | Pages: 4522-4535

10.2174/0929867326666190523083747 | PMID 31119996 Get It

Hospitalization rates and survival of patients with Heart Failure (HF) have improved. However, 5-year mortality rates remain high and the prevalence of the disease is rising likely due to aging of the population and advances in diagnosis and treatment of other acute and chronic cardiovascular diseases. Over the past three decades the therapeutic armamentarium of heart failure has improved substantially with development of medications targeting neuro-hormonal activation and devices preventing sudden cardiac death and improving cardiac synchrony. Recently, inhibition of angiotensin receptors and neprilysin as well as sinoatrial pacemaker modulating f-current, have been found safe and effective strategies that improve HF hospitalization rates and/or mortality. Antidiabetic agents inhibiting sodium-glucose co-transporters 2, result in natriuresis and osmotic diuresis and may further improve HF related outcomes. Furthermore, emerging therapies such as cardiac myosin activators, soluble guanylate cyclase stimulators and non-steroidal mineralocorticoid receptor antagonists are undergoing investigation in phase II and III studies of HF patients. Finally, rapid evolution of in the management of advanced HF has occurred with the application of second and third generation continuous flow left ventricular assist devices in clinical practice. Ongoing clinical studies will validate the safety and efficacy of emerging therapeutic strategies in HF population underrepresented in previous clinical trials.
Anatomical landmarks for localizing the otic ganglion: A possible new treatment target for headache disorders
Crespi, Joan , Bratbak, Daniel Fossum , Matharu, Manjit , Senger, Miriam, Matharu, Manjit Singh , Dodick, David W. , Angelov, Doychin N. , Tronvik, Erling

Mayo Clinic

Cephalalgia Reports | May 23, 2019 | Volume: 2 | Issue: No issue available | Pages: No page available

10.1177/2515816319850761 Get It

Background: The otic ganglion (OG) is a cranial parasympathetic ganglion located in the infratemporal fossa under the foramen ovale (FO) and adjacent to the medial part of the mandibular nerve. Parasympathetic innervation of intracranial vessels from the OG has been shown both in animal and human models and evidence suggests that the OG plays an important role in the cranial vasomotor response. We review the evidence that positions the OG as a viable target for headache disorders. The OG is a small structure and not detectable on medical imaging. The FO is easily identifiable on CT scans and the mandibular nerve on MRI, hence, the position of the OG may be predicted if the mean distance from the FO is known. Objective: The objective is to describe the average distance between the FO and the OG in a sample of 18 infratemporal fossae from 21 cadavers. Methods: A total of 21 high definition photographs of 21 infratemporal fossae from 18 cadavers were analyzed. The distance between the inferior edge of the medial part of the FO to the OG was measured. Results: Four photographs of infratemporal fossae of four cadavers were excluded due to the inability to localize the inferior edge of the FO. A total of 15 infratemporal fossae from 17 cadavers were measured. The mean distance from the FO to the OG was 4.5 mm (SD 1.7), range 2.1–7.7 mm. Conclusions: We have described the average distance from the OG to an easily identifiable anatomical landmark that is visible in CT scans, the FO. This anatomical study may aid in the development of strategies to localize the OG in order to explore its role as a therapeutic target for headache disorders.
Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging
Lundt, Emily S. , Albertson, Sabrina M., Kremers, Walter K. , Bondi, Mark W. , Petersen, Ronald C. , Kremers, Walter K , Machulda, Mary M. , Mielke, Michelle M. , Knopman, David S. , Lundt, Emily S

Mayo Clinic

Alzheimer's & Dementia | May 23, 2019 | Volume: 15 | Issue: 7 | Pages: 878-887

10.1016/j.jalz.2019.03.014 | PMID 31128864 Get It

Abstract Introduction We evaluated whether incident mild cognitive impairment (MCI) subtypes could be empirically derived in the Mayo Clinic Study of Aging. Methods We performed cluster analysis on neuropsychological data from 506 participants with incident MCI. Results The 3‐cluster solution resulted in (1) amnestic, (2) dysexecutive, (3) dysnomic subtypes. The 4‐cluster solution produced these same three groups and a fourth group with subtle cognitive impairment (SCI). The SCI cluster was a subset of the amnestic cluster and distinct from well‐matched cognitively unimpaired participants based on memory and global z‐score area under the receiver operating characteristic curve analyses and probability of progression to MCI/dementia. Discussion We empirically identified three neuropsychological subtypes of MCI that share some features with MCI subtypes identified in the Alzheimer's Disease Neuroimaging Initiative. The fourth subtype with SCI in the Mayo Clinic Study of Aging differed from the fourth cluster‐derived normal group in Alzheimer's Disease Neuroimaging Initiative and could represent a group to target with early interventions.